Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Permanent Congenital Hypothyroidism in Isfahan-Iran



Hashemipour M1 ; Ghasemi M2 ; Hovsepian S3 ; Heiydari K4 ; Sajadi A4 ; Hadian R4 ; Mansourian M5 ; Mirshahzadeh N6 ; Dalvi M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pediatric Endocrinology, Isfahan Endocrine and Metabolism Research Center, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Pediatrics, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Isfahan Health Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Biostatistics and Epidemiology, Health School, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Isfahan Endocrine and Metabolic, Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2013

Abstract

Background: Considering the importance to determine the reasons for the higher occurrence of congenital hypothyroidism (CH) in Iran, in this study we report the prevalence of permanent CH (PCH) in Isfahan province 7 years after initiation of CH screening program in Isfahan. Methods: In this cross-sectional study, children with a primary diagnosis of CH studied. They clinically examined and their medical files were reviewed by a pediatric endocrinologist. Considering screening and follow-up lab data, radiologic findings and the decision of pediatric endocrinologists the final diagnosis of PCH was determined. Results: A total of 464,648 neonates screened in Isfahan province. The coverage percent of the CH screening and recall rate was 98.9% and 2.1%, respectively. A total of 1990 neonates were diagnosed with primary CH. PCH was diagnosed in 410 neonates. The prevalence of PCH and transient CH (TCH) was 1 in 1133 and 1 in 294 live births. The most common etiology of CH was thyroid dyshormonogenesis. Conclusions: Though the prevalence of PCH is high, but the higher prevalence of CH in Isfahan is commonly due to cases with TCH. Hence, the necessity of determining new strategies for earlier diagnosis of patients with TCH is recommended.
Other Related Docs
10. The Role of Ultrasonography in Primary Congenital Hypothyroidism, Journal of Research in Medical Sciences (2011)
33. Different Aspects of Kidney Function in Well-Controlled Congenital Hypothyroidism, JCRPE Journal of Clinical Research in Pediatric Endocrinology (2012)
35. Hearing Impairment in Congenitally Hypothyroid Patients, Iranian Journal of Pediatrics (2012)
36. Age of Menarche and Final Height in Patients With Permanent Congenital Hypothyroidism, Annals of Pediatric Endocrinology and Metabolism (2024)
38. Congenital Hypothyroidism; Is There Any Familial Component?, Journal of Isfahan Medical School (2009)
45. Guideline for the Treatment of Hypothyroidism in Prematurity, International Journal of Preventive Medicine (2021)
47. Isfahan Thyroid Cohort Study (Itcs), Archives of Iranian Medicine (2021)